首页> 外文会议>Conference on Physics of Medical Imaging >In silico imaging clinical trials for regulatory evaluation: initial considerations for VICTRE, a demonstration study
【24h】

In silico imaging clinical trials for regulatory evaluation: initial considerations for VICTRE, a demonstration study

机译:用于监管评估的计算机成像临床试验:VICTRE的初步考虑,一项示范性研究

获取原文

摘要

Expensive and lengthy clinical trials can delay regulatory evaluation and add significant burden that stifles innovation affecting patient access to novel, high-quality imaging technologies. In silico imaging holds promise for evaluating the safety and effectiveness of imaging technologies with much less burden than clinical trials. We define in silico imaging as a computer simulation of an entire imaging system (including source, object, task, and observer components) used for research, development, optimization, technology assessment, and regulatory evaluation of new technology. In this work we describe VICTRE (our study of virtual imaging clinical trials for regulatory evaluation) and the considerations for building an entire imaging pipeline in silico including device (physics), patient (anatomy, disease), and image interpretation models for regulatory evaluation using open-source tools.
机译:昂贵而漫长的临床试验可能会延迟监管评估,并增加沉重的负担,扼杀创新,影响患者对新颖,高质量成像技术的获取。计算机成像技术有望以比临床试验少得多的负担来评估成像技术的安全性和有效性。我们将计算机成像定义为整个成像系统(包括源,对象,任务和观察者组件)的计算机模拟,用于整个新技术的研究,开发,优化,技术评估和法规评估。在这项工作中,我们描述了VICTRE(我们对虚拟成像临床试验进行监管评估的研究),以及在计算机上构建包括设备(物理),患者(解剖结构,疾病)和用于进行监管评估的图像解释模型的整个成像管道的注意事项开源工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号